Transumbilical Single Incision Versus Conventional Three Incisions Laparoscopic Appendicectomy
Double Blinded Randomized Controlled Study of Conventional Laparoscopic Appendicectomy Versus Transumbilical Single Incision Laparoscopic Appendicectomy
1 other identifier
interventional
80
1 country
1
Brief Summary
Laparoscopic appendicectomy is widely practiced in Hong Kong nowadays with shorter hospital stay and less wound complications. Most of the time, three small wounds of less than 10mm will be adequate enough for the completion of the surgery with minimal pain. Recently, the concept of Natural Orifice Transluminal Endoscopic Surgery (N.O.T.E.S) led to the attention of single incision laparoscopic surgery (SILS) again in the surgical community. SILS is not a new idea. The first SILS for cholecystectomy was reported in 1997 by Navarra et al. However, the close proximity of the instruments, limitation in triangulation during dissection and suboptimal exposure of the surgical field has made this approach unpopular in last decade. Because the concept of N.O.T.E.S and the newly designed access port, surgeons are now focused again on SILS. The Chinese University of Hong Kong has recently release their preliminary results on the use of SILS on appendicectomy with satisfactory results in terms of less post-operative pain and less prominent scar. However, it was a case series with limited number of patients. In order to test the advantages of SILS on the management of patients with acute appendicitis, a double blinded randomized clinical trial is conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 30, 2009
CompletedFirst Posted
Study publicly available on registry
December 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFebruary 12, 2014
February 1, 2014
11 months
November 30, 2009
February 11, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
wound infection rate
2 weeks after surgery
Secondary Outcomes (1)
cosmetic satisfaction
2 weeks after surgery
Study Arms (2)
single port
ACTIVE COMPARATORPatients will undergo transumbilical single incision laparoscopic appendicectomy.
conventional Lap
ACTIVE COMPARATORPatients will undergo conventional laparoscopic appendicectomy.
Interventions
Patients will undergo transumbilical single incision laparoscopic appendicectomy. A single incision is made on umbilicus within the margin of umbilical skin ring. Peritoneal cavity is entered by open method and the fascia layer can be extended up to 2.5cm in length. A single incision laparoscopic device (Olympus) will be inserted. Conventional laparoscopic instruments will be used. Umbilical fascia will be closed by PDS-1 J-shape needle. Marcain 0.5% should be infiltrated into the fascial layers as well as the skin layers with dosage up to 20ml. The umbilicus is reconstructed by interrupted 3-0 nylon by tacking the skin onto the fascia layers. Three non-transparent dressings will be placed as if conventional laparoscopic appendicectomy has been done.
Patients will undergo conventional laparoscopic appendicectomy. A 10-mm subumbilical port will be inserted by open method. Two 5-mm working ports will be inserted under laparoscopic view at patient's left lower quadrant and suprapubic area. Umbilical fascia will be closed by PDS-1 J-shape needle. Local anaesthetic agent , Marcain 0.5% should be infiltrated into the fascial layers as well as the skin layers with dosage up to 20ml. All skin wound will be approximated with 3-0 nylon interrupted stitches and covered with non-transparent dressings.
Eligibility Criteria
You may qualify if:
- Patients will be at least 18 years of age.
- Male or female (excluding pregnant females).
- Patients with ASA ≦ 3.
- Patients informed about the study, and will have read; understood and signed the patient informed consent. Patients will be willing and able to submit to postoperative follow-up evaluations.
You may not qualify if:
- Patients have previous history of abdominal surgery.
- Patients with ASA \> 3.
- Patients with any conditions that were not suspected preoperatively and are only discovered at the time of the operation.
- Patients who are incompetent in giving consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pamela Youde Nethersole Eastern Hospital
Hong Kong, Hong Kong, 852, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in general surgery
Study Record Dates
First Submitted
November 30, 2009
First Posted
December 2, 2009
Study Start
October 1, 2009
Primary Completion
September 1, 2010
Study Completion
March 1, 2013
Last Updated
February 12, 2014
Record last verified: 2014-02